Jane Wasman

2019

In 2019, Jane Wasman earned a total compensation of $2.4M as Former President, International, General Counsel and Corporate Secretary at Acorda Therapeutics, a 67% increase compared to previous year.

Compensation breakdown

Bonus$17,100
Non-Equity Incentive Plan$342,540
Option Awards$273,550
Salary$570,900
Stock Awards$288,506
Other$918,953
Total$2,411,549

Wasman received $919K in other compensation, accounting for 38% of the total pay in 2019.

Wasman also received $17.1K in bonus, $342.5K in non-equity incentive plan, $273.6K in option awards, $570.9K in salary and $288.5K in stock awards.

Rankings

In 2019, Jane Wasman's compensation ranked 5,013th out of 13,971 executives tracked by ExecPay. In other words, Wasman earned more than 64.1% of executives.

ClassificationRankingPercentile
All
5,013
out of 13,971
64th
Division
Manufacturing
1,863
out of 5,701
67th
Major group
Chemicals And Allied Products
656
out of 2,200
70th
Industry group
Drugs
554
out of 1,886
71st
Industry
Biological Products, Except Diagnostic Substances
125
out of 389
68th

Pay ratio

Jane Wasman's Pay$2,411,549
Median Employee's Pay$179,362
Pay Ratio

13

to 1

In 2019, the annual total compensation of Jane Wasman was $2,411,549.

The annual total compensation of the median employee at Acorda Therapeutics was $179,362.

The ratio of Jane Wasman's pay to the pay of median employee was therefore 13 to one.

Source: SEC filing on April 28, 2020.

Wasman's colleagues

We found four more compensation records of executives who worked with Jane Wasman at Acorda Therapeutics in 2019.

2019

Ron Cohen

Acorda Therapeutics

Chief Executive Officer

2019

Burkhard Blank

Acorda Therapeutics

Chief Medical Officer

2019

Lauren Sabella

Acorda Therapeutics

Chief Commercial Officer

2019

David Lawrence

Acorda Therapeutics

Chief, Business Operations and Principal Accounting Officer

News

You may also like